Find your future career

Join Grünenthal

experienced professionals

Stronger together:

Take up the challenge

Young Professionals

Come on board:

Kick start your career

Students

Get experience:

Internships for students

Logo Be!Grünenthal

We research, we develop, we bring true innovations to the marketplace. Is that also your goal? Do you also want to sustainably improve the lives of our patients?

Are you an innovative researcher, an unconventional thinker, a strategist, a visionary, a creative thinker, a pragmatist, or a go-getter? In short, are you a person who will rise to the challenge and make a difference?

Then we look forward to telling you more about Grünenthal—about us, what makes us tick, and how we can reach our goals together - every day, worldwide.

Annette, Communications Management, experienced professionals, Grünenthal, wide range of challenges, contribute to the company’s success

Annette, Communications Management

"There’s a wide range of challenges in an inspiring environment here. It’s great to contribute to the company’s success.”

What drives us and what we do - Stay up to date with all the happenings at Grünenthal

Our news


28 Aug 2018

Duzallo®, a fixed-dose combination therapy for gout, approved in Europe

Aachen, Germany, 28 August 2018 – Today, Grünenthal announced that the European Commission has followed the positive opinion of the Committee for Medicinal Products for Human Use (CHMP) and granted Duzallo® marketing authorization for the EU/EEA. Duzallo® is a fixed-dose combination (FDC) therapy that combines allopurinol and lesinurad. It is indicated for the treatment of hyperuricaemia in adult gout patients who have not been able to reach target levels of uric acid serum with a dose of allopurinol alone. Lesinurad is the first innovative uricosuric in gout treatment for over 40 years.

More ...

15 Jun 2018

Grünenthal selected as one of the best employers in Europe for the third time

Aachen, Germany, 15 June 2018 – Grünenthal has qualified as one of the 25 Best Multinational Workplaces in Europe this year. After 2012 and 2013, this is the third time that Grünenthal, a science-based pharmaceutical company headquartered in Germany, is being awarded in this category. National successes in Italy, Portugal and Spain were the reasons for the decision by the Great Place to Work® (GPtW®) Institute.

More ...

next [2]

awards